阿斯利康以高达72亿元收购一家体内细胞疗法公司

生物科技馆
21 May

阿斯利康5月20日宣布成功完成对EsoBiotec的收购。EsoBiotec是比利时一家细胞技术公司,致力于开创体内细胞疗法,并已展现出良好的早期临床效果。阿斯利康已同意以高达10亿美元(约72亿元人民币或7.5亿英镑)的价格收购一家比利时生物科技公司EsoBiotec。此次收购包括这家比利时公司的体内递送平台,阿斯利康——这家剑桥制药巨头表示,该平台有可能改变细胞疗法。EsoBiotec 工程...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10